High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples